Study No. VX12-950-121: Retrospective Review of Baseline, On-Treatment, and Outcome Data for Patients in the United States Treated With Telaprevir After Marketing Approval

Project: Research project

Project Details

StatusFinished
Effective start/end date12/21/1212/21/15

Funding

  • Vertex Pharmaceuticals Incorporated (Study No. VX12-950-121)